| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pulmonary Heart Disease | D011660 | 2 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Diseases in Twins | D004200 | 4 associated lipids |
| Bartter Syndrome | D001477 | 5 associated lipids |
| Carotid Artery Thrombosis | D002341 | 7 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
| Respiratory Syncytial Virus Infections | D018357 | 10 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Alcoholic Intoxication | D000435 | 15 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Vesterqvist O et al. | Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans. | 1987 | Res Exp Med (Berl) | pmid:3303204 |
| Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
| Gréen K et al. | Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus. | 1988 | Acta Endocrinol. | pmid:3291538 |
| Minuz P et al. | Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. | 1988 | Hypertension | pmid:3290103 |
| Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
| Fitzgerald DJ et al. | Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. | 1988 | J. Clin. Invest. | pmid:3183064 |
| Seyberth HW et al. | Excretion of primary prostanoids and their metabolites during acute volume expansion. | 1988 | Prostaglandins | pmid:3163156 |
| Lassila R et al. | Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. | 1988 | BMJ | pmid:3142565 |
| Vericel E et al. | Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. | 1988 | Thromb. Res. | pmid:3129819 |
| Reilly IA et al. | Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. | 1986 | Br Med J (Clin Res Ed) | pmid:3083991 |
| Rosenkranz B et al. | Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. | 1986 | Br J Clin Pharmacol | pmid:3083851 |
| Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |
| Knapp HR et al. | In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. | 1986 | N. Engl. J. Med. | pmid:3007982 |
| Ylikorkala O et al. | Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. | 1987 | J. Clin. Endocrinol. Metab. | pmid:2960690 |
| Castagnoli MN et al. | Combined high-performance liquid chromatography and enzyme immunoassay for the determination of urinary metabolites of thromboxane and 6-keto-PGF1 alpha. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960164 |
| Ciabattoni G et al. | Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960163 |
| Edlund A et al. | Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959097 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane A2 and prostaglandin I2 in healthy and diseased individuals. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959096 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites. | 1986 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2949557 |
| Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |